Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LEVOMILNACIPRAN HYDROCHLORIDE

LEVOMILNACIPRAN HYDROCHLORIDE

Standard Dose
EQ 20MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LEVOMILNACIPRAN HYDROCHLORIDE is listed in Drugs@FDA under application 210826 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOMILNACIPRAN HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - EQ 20MG BASE Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2023-01-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEVOMILNACIPRAN HYDROCHLORIDE is listed in Drugs@FDA under application 210826 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVOMILNACIPRAN HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - EQ 20MG BASE Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2023-01-06 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.